| Zavicefta (ceftazidime/avibactam) / Pfizer, AbbVie |
NCT00752219 / 2008-005604-54: Prospective Multicenter Doubleblind Randomized Study of NXL104/Ceftazidime + Metronidazole vs. Meropenem in Treatment of Complicated Intra-abdominal Infections |
|
|
| Completed | 2 | 204 | US, Europe, RoW | ceftazidime/NXL104 + metronidazole, meropenem, merrem | Pfizer | Complicated Intra-abdominal Infections | 11/09 | 12/09 | | |
NCT00690378: Comparative Study of NXL104/Ceftazidime Versus Comparator in Adults With Complicated Urinary Tract Infections |
|
|
| Completed | 2 | 137 | US, RoW | NXL104/ceftazidime, Imipenem/Cilastatin | Pfizer | Complicated Urinary Tract Infection | 06/10 | 07/10 | | |
NCT02475733 / 2014-003242-28: Evaluation of Safety,Pharmacokinetics and Efficacy of CAZ-AVI With Metronidazole in Children Aged 3 Months to 18 Years Old With Complicated Intra-abdominal Infections (cIAIs). |
|
|
| Completed | 2 | 83 | US, Europe, RoW | Ceftazidime -avibactam, Meropenem, Metronidazole | Pfizer | Complicated Intra-abdominal Infections | 06/17 | 06/17 | | |
NCT02497781 / 2014-003244-13: Evaluation of Safety, Pharmacokinetics and Efficacy of Ceftazidime and Avibactam (CAZ-AVI ) Compared With Cefepime in Children From 3 Months to Less Than 18 Years of Age With Complicated Urinary Tract Infections (cUTIs) |
|
|
| Completed | 2 | 97 | US, Europe, RoW | Ceftazidime -avibactam, Cefepime | Pfizer, PRA Health Sciences | Complicated Urinary Tract Infections | 09/17 | 09/17 | | |
| Terminated | 2 | 48 | Europe, US, RoW | Part A: Single Dose Ceftazidime-Avibactam, Cohorts 1-3, Part B: Multiple-dose Ceftazidime-Avibactam, Cohorts 1-3 | Pfizer, Allergan | Gram-negative Bacterial Infection | 12/22 | 12/22 | | |
2020-001416-15: Concentration of the antibiotic Ceftazidime-Avibactam in bile fluid |
|
|
| Completed | 2 | 12 | Europe | Zavicefta, Powder for concentrate for solution for infusion, Zavicefta 2g/0,5g | Universitätsklinikum Knappschaftskrankenhaus Bochum GmbH, Pfizer Pharma PFE GmbH | N/A => Pharmacokinetic study, N/A => Study to measure the concentration of the antibiotic (Ceftazidim/Avibactam) in bile fluid, Diseases [C] - Bacterial Infections and Mycoses [C01] | | | | |
